2023-01-25 10:00:28

New Lawsuit Challenges State Bans on Abortion Pills

Logo The New York Times
The New York Times
By Pam Belluck

The case, brought by GenBioPro, a company that makes one of two abortion drugs, argues that it is unconstitutional for a state to bar access to a medication approved by the federal government.

A company that makes an abortion pill filed a lawsuit Wednesday morning challenging the constitutionality of a state ban on the medication, the first in what is expected to be a wave of cases arguing that the federal Food and Drug Administrations approval of the pill takes precedence over such restrictive state laws.

The case was filed in federal court in West Virginia by GenBioPro, one of two American manufacturers of mifepristone, the first pill used in the two-drug medication abortion regimen. A ruling in favor of the company could compel other states that have banned abortion to allow the pills to be prescribed, dispensed and sold, according to legal experts. If the courts reject the companys arguments, some legal scholars say the decision could open the door for states to ban or restrict other approved drugs, such as Covid vaccines or morning-after pills.

Continue read on nytimes.com

Logo CNBC
Business / FinanceBy Spencer Kimball2023-01-24 13:36:05
Key Points Anti-abortion physicians are suing to overturn the FDA's approval of mifepristone, which dates back more than two decades. Mifepristone used in...

Logo U.S. News & World Report
PoliticsBy Associated Press2023-01-24 18:23:03
PIERRE, S.D. (AP) South Dakota Gov. Kristi Noem, along with the state's Republican attorney general, said Tuesday the state will prosecute pharmacists who...

Logo U.S. News & World Report
PoliticsBy Associated Press2023-01-24 18:22:33
TALLAHASSEE, Fla. (AP) Florida s ban on abortions after 15 weeks of pregnancy will be allowed to stand until a hearing before the state Supreme Court. The...

Logo POLITICO
HealthBy Alice Miranda Ollstein2023-01-25 09:30:00
SANTA BARBARA, Calif. Nurses at the low-slung maze-like student health complex at the University of California, Santa Barbara work year-round to make sure...

Logo U.S. News & World Report
PoliticsBy Associated Press2023-01-23 19:15:55
ALBUQUERQUE, N.M. (AP) New Mexico s top prosecutor on Monday asked the state Supreme Court to nullify abortion ordinances that local elected officials have...

Logo PR Newswire
NEW YORK, Jan. 24, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Y-mAbs...

Logo PR Newswire
HealthPress Release2023-01-24 19:08:00
Driven by the Dobbs decision, investors seeking action on benefits, data privacy, political spending, and more SAN FRANCISCO, Jan. 24, 2023 /PRNewswire/ --...

Logo GlobeNewswire
The global genitourinary drugs market size was valued at USD 32 billion in 2021 and is expected to surpass USD 68.51 billion by 2030, registering a CAGR of...

Logo U.S. News & World Report
PoliticsBy Kaiser Health News2023-01-23 22:00:22
By Julie Rovner | KHN Anti-abortion advocates are pressing for expanded abortion bans and tighter restrictions since the Supreme Court overturned the...

Logo U.S. News & World Report
PoliticsBy Associated Press2023-01-24 17:35:11
ALBANY, N.Y. (AP) New York s Legislature is poised to take another step Tuesday toward adopting a constitutional amendment that would bar discrimination...

Logo Benzinga
Business / FinanceBy Business Wire2023-01-24 23:55:00
Today, prominent investor rights law firm Bernstein Litowitz Berger & Grossmann LLP ("BLB&G") filed a class action lawsuit in the U.S. District Court...

Logo Benzinga
Business / FinanceBy Business Wire2023-01-24 23:46:00
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the stock of Bioventus Inc....

Logo Benzinga
Business / FinanceBy Business Wire2023-01-25 03:13:00
Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until March...

Logo Benzinga
Business / FinanceBy Business Wire2023-01-24 02:00:00
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Bioventus...

Logo PR Newswire
HealthPress Release2023-01-24 10:56:00
Two successful exits – Syndesi and BioPhero Four portfolio companies reported clinical data from first in class targets (Galecto, NMD Pharma, Heparegenix and...

Logo PR Newswire
HealthPress Release2023-01-20 22:38:00
WASHINGTON, Jan. 20, 2023 /PRNewswire/ -- Family Research Council, along with thirteen other pro-life organizations, today sent letters addressed to the...

Logo U.S. News & World Report
PoliticsBy Associated Press2023-01-25 02:09:39
SPRINGFIELD, Ill. (AP) Illinois' two-week-old ban on semiautomatic weapons outlaws ubiquitous firearms in radical defiance of the Constitution's Second...

Logo GlobeNewswire
SciencePress Release2023-01-24 19:00:00
Company Announcement COPENHAGEN, Denmark; January 24, 20 2 3 Genmab A/S ( Nasdaq: GMAB ) a nnounced today that the Board decided to grant 5,408 restricted...

Logo Channel NewsAsia
Business / FinanceBy Cna2023-01-25 05:35:24
Best News Website or Mobile Service WAN-IFRA Digital Media Awards Worldwide Best News Website or Mobile Service Digital Media Awards Worldwide Crypto asset...

Logo GlobeNewswire
SciencePress Release2023-01-24 11:27:00
Company Announcement Net sales of DARZALEX in 2022 totaled USD 7, 977 million Genmab receives royalties on worldwide net sales from Janssen Biotech, Inc....